Beaverton, OR – May 20, 2026 – Novogene, a leader in genomic services and solutions, proudly celebrates the grand opening of its new state-of-the-art mass spectrometry laboratory in Beaverton, Oregon. This milestone marks a significant step in Novogene’s strategic expansion into mass spectrometry-based proteomics services across North America, reinforcing its commitment to advancing genomic and proteomic research and innovation.

The grand opening ceremony brought together key industry leaders, including Douglas Zhang, Vice President of Novogene Americas; Guanghui Han, General Manager of Proteomics; and Michelle Steel, Vice President of Sales for the Americas in Thermo Fisher Scientific’s Chromatography and Mass Spectrometry Division. Their participation underscores the strong collaboration between Novogene and leading technology partners in advancing proteomics innovation.

The event featured opening remarks, a ribbon-cutting ceremony, and guided tours of the facility, offering guests a firsthand look at the advanced mass spectrometry platform and workflows now available to our clients across both North and South America.

Coinciding with the lab opening, Novogene officially launched its DIA (Data-Independent Acquisition) quantitative proteomics service, powered by the Thermo Scientific Orbitrap Astral platform.

As part of the launch, Novogene completed comprehensive internal benchmarking of deep/rapid DIA proteomics and phosphoproteomics across diverse biological sample types, as well as plasma/serum proteomics. The evaluation demonstrated industry-leading sensitivity and throughput in protein identification and quantification, confirming the workflow’s robustness and reproducibility.

By optimizing laboratory and analytical procedures, Novogene delivers a state-of-the-art solution designated to meet evolving research needs in immunology, oncology, neuroscience, infectious disease and other translational and discovery-driven fields with leading performance and competitive pricing. By maintaining consistent technical standards across workflows, Novogene continues to support diverse research needs in proteomics with an advanced mass spectrometry platform, innovative technology, and a comprehensive bioinformatics analysis package.

To support early adoption, Novogene is offering a limited-time promotional incentive for its newly launched proteomics services: https://web.novogene.com/Website_Early_Access_promotion_proteomics

For more information about Novogene’s DIA quantitative proteomics service, please visit: quantitative-proteomics